Header cover image

German (DAX) Pharma Industry Analysis

UpdatedApr 11, 2026
DataAggregated Company Financials
Companies9
  • 7D1.3%
  • 3M-9.5%
  • 1Y25.4%
  • YTD-1.9%

In the last week, the Pharma industry is up 1.3%, with Merck KGaA up 1.9%. In the same time, Dermapharm Holding was down 7.0%. In the last 12 months, the industry was up 25%. Looking forward, earnings are forecast to grow by 28% annually.

Industry Valuation and Performance

Has the German Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 11 Apr 2026€91.1b€67.9b-€883,890,069.5618.3x-103x1.3x
Mon, 09 Mar 2026€86.4b€67.9b-€902,794,919.1418.1x-95.7x1.3x
Wed, 04 Feb 2026€100.5b€68.3b€2.9b17.1x35.1x1.5x
Fri, 02 Jan 2026€92.6b€68.3b€2.9b18.1x32.3x1.4x
Sun, 30 Nov 2025€83.6b€68.5b€2.9b17.5x29x1.2x
Tue, 28 Oct 2025€79.9b€68.8b-€439,054,716.7619.1x-181.9x1.2x
Thu, 25 Sep 2025€77.1b€68.8b-€438,193,335.1417.9x-175.9x1.1x
Sat, 23 Aug 2025€79.9b€68.9b-€409,723,954.9217.5x-195.1x1.2x
Mon, 21 Jul 2025€77.7b€69.4b-€283,071,598.0017.4x-274.5x1.1x
Wed, 18 Jun 2025€77.9b€69.4b-€206,268,848.0017.8x-377.8x1.1x
Fri, 16 May 2025€75.2b€69.4b-€206,564,479.0018.1x-363.9x1.1x
Sun, 13 Apr 2025€72.5b€69.3b€467.0m17.7x155.2x1x
Tue, 11 Mar 2025€84.3b€69.2b€436.0m21.1x193.4x1.2x
Thu, 06 Feb 2025€84.9b€69.2b€2.0b22.8x41.9x1.2x
Sat, 04 Jan 2025€82.3b€69.2b€2.0b22.6x41x1.2x
Mon, 02 Dec 2024€83.1b€69.2b€2.0b21.4x41x1.2x
Wed, 30 Oct 2024€93.6b€69.4b€1.6b20.6x60x1.3x
Fri, 27 Sep 2024€100.6b€69.4b€1.5b24.6x68.3x1.5x
Sun, 25 Aug 2024€104.4b€69.3b€1.5b31.2x71.6x1.5x
Tue, 23 Jul 2024€94.5b€69.2b-€303,627,757.0029x-311.4x1.4x
Thu, 20 Jun 2024€98.9b€69.2b-€328,028,608.0026.2x-301.6x1.4x
Sat, 18 May 2024€103.4b€69.2b-€312,802,180.0021.7x-330.5x1.5x
Mon, 15 Apr 2024€95.7b€70.0b-€34,208,180.0020.8x-2796.8x1.4x
Wed, 13 Mar 2024€98.7b€70.0b€6.5m20x15196.9x1.4x
Fri, 09 Feb 2024€95.5b€70.6b-€650,504,143.0019.5x-146.8x1.4x
Sun, 07 Jan 2024€99.2b€70.6b-€650,504,143.0020x-152.5x1.4x
Tue, 05 Dec 2023€103.3b€70.6b-€650,606,256.0018.9x-158.8x1.5x
Thu, 02 Nov 2023€104.3b€72.1b€4.7b17.2x22.3x1.4x
Sat, 30 Sep 2023€116.1b€72.1b€4.7b22x24.8x1.6x
Mon, 28 Aug 2023€122.1b€72.1b€4.7b22.6x26.2x1.7x
Wed, 26 Jul 2023€122.1b€74.1b€6.5b18.9x18.9x1.6x
Fri, 23 Jun 2023€119.1b€74.1b€6.4b20.5x18.6x1.6x
Sun, 21 May 2023€129.1b€74.0b€6.4b22.3x20.3x1.7x
Tue, 18 Apr 2023€135.1b€74.2b€7.6b19.2x17.7x1.8x
Price to Earnings Ratio

17.7x


Total Market Cap: €135.1bTotal Earnings: €7.6bTotal Revenue: €74.2bTotal Market Cap vs Earnings and Revenue0%0%0%
German Pharma Industry Price to Earnings3Y Average 128.2x202420252026
Current Industry PE
  • Investors are relatively neutral on the German Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 2.9% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market2.93%
Healthcare2.34%
Pharma1.26%
Pharma1.26%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MRK Merck KGaA€111.851.9%
+€891.3m
-3.0%PE18.6x
BAYN Bayer€40.121.1%
+€417.5m
99.0%PS0.9x
HIGH Cantourage Group€4.721.5%
+€872.9k
2.8%PS30.1x
B8FK Biofrontera€2.573.2%
+€486.1k
4.5%PS0.7x
27N0 Cannovum Cannabis€0.368.0%
+€62.4k
45.6%n/a

Latest News